{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:53:15Z","timestamp":1781549595578,"version":"3.54.5"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Recent studies have reported the possible link between adeno-associated virus 2 (AAV2) and severe pediatric acute hepatitis. It has been suggested that aberrant AAV2 replication initiated by coinfection with \u201chelper viruses\u201d such as human adenovirus and human herpesvirus-6B (HHV-6B) may induce abnormal immune responses. Encephalitis\/encephalopathy is a severe complication of primary HHV-6B infection, but the underlying mechanisms remain unclear. This study analyzed the association between AAV2 coinfection and neurologic complications of primary HHV-6B infection in children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Preserved serum samples obtained from 36 patients with HHV-6B-associated encephalitis\/encephalopathy, 39 with febrile seizure, and 83 without neurologic complications were retrospectively analyzed. Primary HHV-6B infection was confirmed if HHV-6B DNA was detected and the HHV-6B antibody was negative in serum. AAV2 and HHV-6 DNA loads were quantitated using real-time PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      AAV2 was detected in 4 (11%) and 3 (8%) patients in the encephalitis\/encephalopathy and febrile seizure groups, respectively. In contrast, AAV2 was undetectable in 83 patients without neurologic complications. AAV2 detection frequency was significantly higher in the encephalitis\/encephalopathy and febrile seizure groups compared with the no neurologic complications group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03, respectively). Among 4 patients with HHV-6B-associated encephalitis\/encephalopathy, AAV2 DNA was detected in the cerebrospinal fluid of 2 patients. Serum HHV-6B DNA load was not significantly different among patients who were AAV2 positive or AAV negative and with or without neurologic complications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These findings suggest that coinfection of AAV2 and HHV-6B is associated with neurologic complications such as encephalitis\/encephalopathy and febrile seizure in children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004924","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T17:00:34Z","timestamp":1756486834000},"page":"1231-1236","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Association Between Adeno-associated Virus 2 and Neurologic Complications of Pediatric Human Herpesvirus-6B Infection"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1553-2539","authenticated-orcid":false,"given":"Jun-ichi","family":"Kawada","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Higashimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Fujita Health University School of Medical Sciences, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"},{"name":"Department of Pediatrics, Fujita Health University Okazaki Medical Center, Okazaki, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Toyokawa City Hospital, Toyokawa, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Ite","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Fujita Health University School of Medical Sciences, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuna","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Fujita Health University School of Medical Sciences, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Torii","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsushi","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"R1-20260615","doi-asserted-by":"crossref","first-page":"e0128224","DOI":"10.1128\/jvi.01282-24","article-title":"AAV2 can replicate its DNA by a rolling hairpin or rolling circle mechanism, depending on the helper virus.","volume":"98","author":"Lkharrazi","year":"2024","journal-title":"J Virol"},{"key":"R2-20260615","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases.","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R3-20260615","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-023-05948-2","article-title":"Adeno-associated virus 2 infection in children with non-A-E hepatitis.","volume":"617","author":"Ho","year":"2023","journal-title":"Nature"},{"key":"R4-20260615","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41586-023-05949-1","article-title":"Adeno-associated virus type 2 in US children with acute severe hepatitis.","volume":"617","author":"Servellita","year":"2023","journal-title":"Nature"},{"key":"R5-20260615","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41586-023-06003-w","article-title":"Genomic investigations of unexplained acute hepatitis in children.","volume":"617","author":"Morfopoulou","year":"2023","journal-title":"Nature"},{"key":"R6-20260615","doi-asserted-by":"crossref","first-page":"102462","DOI":"10.1016\/j.jiac.2024.07.002","article-title":"Association between adeno-associated virus 2 and severe acute hepatitis of unknown etiology in Japanese children.","volume":"31","author":"Iwata","year":"2025","journal-title":"J Infect Chemother"},{"key":"R7-20260615","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM199408183310703","article-title":"Human herpesvirus-6 infection in children. A prospective study of complications and reactivation.","volume":"331","author":"Hall","year":"1994","journal-title":"N Engl J Med"},{"key":"R8-20260615","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pediatrneurol.2020.03.015","article-title":"Clinical features of complex febrile seizure caused by primary human herpesvirus 6B infection.","volume":"109","author":"Miyake","year":"2020","journal-title":"Pediatr Neurol"},{"key":"R9-20260615","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pediatrneurol.2007.05.011","article-title":"Primary human herpesvirus-6 infection in the central nervous system can cause severe disease.","volume":"37","author":"Mannonen","year":"2007","journal-title":"Pediatr Neurol"},{"key":"R10-20260615","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.braindev.2020.04.006","article-title":"Epidemiological changes of acute encephalopathy in Japan based on national surveillance for 2014-2017.","volume":"42","author":"Kasai","year":"2020","journal-title":"Brain Dev"},{"key":"R11-20260615","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum Gene Ther"},{"key":"R12-20260615","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1542\/peds.84.4.675","article-title":"Distribution of antibodies to a causative agent of exanthem subitum (human herpesvirus-6) in healthy individuals.","volume":"84","author":"Yoshikawa","year":"1989","journal-title":"Pediatrics"},{"key":"R13-20260615","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/hgtb.2011.034","article-title":"Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences.","volume":"23","author":"Aurnhammer","year":"2012","journal-title":"Hum Gene Ther Methods"},{"key":"R14-20260615","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1006\/viro.1994.1535","article-title":"Human herpesvirus 6 (HHV-6) is a helper virus for adeno-associated virus type 2 (AAV-2) and the AAV-2 rep gene homologue in HHV-6 can mediate AAV-2 DNA replication and regulate gene expression.","volume":"204","author":"Thomson","year":"1994","journal-title":"Virology"},{"key":"R15-20260615","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jhep.2023.10.029","article-title":"Adeno-associated viruses for gene therapy - clinical implications and liver-related complications, a guide for hepatologists.","volume":"80","author":"M\u00fccke","year":"2023","journal-title":"J Hepatol"},{"key":"R16-20260615","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ymthe.2024.02.002","article-title":"High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury.","volume":"32","author":"Hordeaux","year":"2024","journal-title":"Mol Ther"},{"key":"R17-20260615","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41434-023-00405-1","article-title":"Adeno-associated virus vectors and neurotoxicity-lessons from preclinical and human studies.","volume":"32","author":"Stone","year":"2025","journal-title":"Gene Ther"},{"key":"R18-20260615","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/brain\/awy126","article-title":"A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency.","volume":"141","author":"Tordo","year":"2018","journal-title":"Brain"},{"key":"R19-20260615","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/13550280600827351","article-title":"Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex.","volume":"12","author":"Hobbs","year":"2006","journal-title":"J Neurovirol"},{"key":"R20-20260615","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/jmv.21808","article-title":"Comparison of the levels of human herpesvirus 6 (HHV-6) DNA and cytokines in the cerebrospinal fluid and serum of children with HHV-6 encephalopathy.","volume":"82","author":"Kawabe","year":"2010","journal-title":"J Med Virol"},{"key":"R21-20260615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13365-016-0473-0","article-title":"Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.","volume":"23","author":"Ongr\u00e1di","year":"2017","journal-title":"J Neurovirol"},{"key":"R22-20260615","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jmv.23788","article-title":"Cytokine and chemokine responses in the blood and cerebrospinal fluid of patients with human herpesvirus 6B-associated acute encephalopathy with biphasic seizures and late reduced diffusion.","volume":"86","author":"Kawamura","year":"2014","journal-title":"J Med Virol"},{"key":"R23-20260615","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/infdis\/170.3.678","article-title":"Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis.","volume":"170","author":"Aurelius","year":"1994","journal-title":"J Infect Dis"},{"key":"R24-20260615","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3390\/v13112286","article-title":"Meningitis caused by the live varicella vaccine virus: metagenomic next generation sequencing, immunology exome sequencing and cytokine multiplex profiling.","volume":"13","author":"Ramachandran","year":"2021","journal-title":"Viruses"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:00:58Z","timestamp":1781546458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004924","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}